Hpgc Renmintongtai Pharmaceutical Co., Ltd. (600829)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
10. 74
+0.2
+1.8975%
¥
4.41B Market Cap
- P/E Ratio
0.58% Div Yield
46.75M Volume
- Eps
¥ 10.54
Previous Close Want to track 600829 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | 0.12 |
| | | - | 0.11 |
| | | - | 0.11 |
| | | - | 0 |
| | | - | 0.06 |
| | | - | 0.07 |
| | | - | 0.11 |
| | | - | - |
| | | - | 0 |
600829 Earnings Reports FAQ
What is the earnings per share (EPS) for 600829?
EPS data for 600829 is currently not available, as Hpgc Renmintongtai Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 9 years, the earnings growth rate has been approximately 1,884.1%, reflecting the 600829's performance and SSE market conditions.
When is the next earnings release date?
Hpgc Renmintongtai Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Hpgc Renmintongtai Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600829 at this time, as Hpgc Renmintongtai Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
